Pasar al contenido principal
Main navigation
About us
About us
Our work
Rationale
IDDO Team
Contact us
Our partners
Governance
Governance
IDDO Board
Data Access Committee
Data sharing
Data sharing
Contributing data
Accessing data
IDDO data sharing registrations
Research themes
Research themes
COVID-19
Ebola
Malaria
Visceral leishmaniasis
Medicine Quality
Antimicrobial Resistance
Schistosomiasis & STHs
Febrile illness
Scrub typhus
Trachoma
Other diseases
Research
Research
Malaria Tracking Resistance
Malaria Clinical Trials Toolkit
COVID-19 LSR Tool
VL Tool
Medicine Quality Monitoring Globe
Medicine Quality Scientific Literature Surveyor
Febrile Illness Surveyor
Publications
Tools & resources
News
User account menu
Iniciar sesión
Register
Contact
Bandwidth
Alto
Bajo
Language switcher
English
Français
Español
Toggle navigation
About us
About us
Overview
Our partners
Team
Governance
Governance
COVID-19 Data Access Committee
Data Sharing
Data Sharing
Contributing data
Accessing data
Research
Approved uses of platform data
Living systematic review trials
Medicine Quality monitoring
Publications
Tools and resources
News
Search
Search
Search
News
i
Photo credit Ezra Acayan, World Bank
News Article
02 Ago 2023
COVID-19 Clinical Research Coalition calls for rapid and flexible funding to counter epidemics in low-resource settings
News Article
27 Abr 2023
IDDO at CUGH: connecting with the global health community
i
Dr James Watson
News Article
03 Abr 2023
Dr James Watson becomes IDDO’s new Associate Director
i
Credit Rajat-Sarki, Unsplash
News Article
15 Mar 2023
World Economic Forum blog on IDDO
News Article
20 Ene 2023
IDDO’s latest newsletter is out
News Article
22 Nov 2022
IDDO’s Director recognised as an ASTMH Distinguished International Fellow for 2022
i
Credit: DNDi, Tygerberg Testing-COVID19
News Article
20 Jul 2022
Incomplete reporting of COVID-19 disease severity criteria compromises meta-analysis
News Article
23 Mayo 2022
IDDO’s latest newsletter is out
News Article
27 Abr 2022
IDDO at the Geneva Health Forum 4 May 2022
News Article
28 Feb 2022
ANTICOV trial finds drug combination nitazoxanide + ciclesonide does not reduce risk of hospitalization in COVID-19 outpatients
i
Credit Jessica Lea, DFID
News Article
10 Feb 2022
Applications open for RSTMH 2022 grant programme
News Article
10 Feb 2022
ANTICOV: clinical trial for COVID-19 in low-resource settings to test a new combination treatment, fluoxetine and budesonide
Paginación
Página actual
1
Página
2
Página
3
Siguiente página
››
Última página
Last »